Holen Sie sich die Stockscreener-App
30.97
1.68%
-0.53
Schlusskurs vom Vortag:
$31.50
Offen:
$31.97
24-Stunden-Volumen:
3.58M
Relative Volume:
1.06
Marktkapitalisierung:
$5.52B
Einnahmen:
$644.86M
Nettoeinkommen (Verlust:
$196.05M
KGV:
31.56
EPS:
0.9812
Netto-Cashflow:
$317.50M
1W Leistung:
+1.54%
1M Leistung:
+19.39%
6M Leistung:
+27.71%
1J Leistung:
-54.00%
1-Tages-Spanne:
$30.59
$32.11
1-Wochen-Bereich:
$29.62
$32.11
52-Wochen-Spanne:
$17.15
$71.37
Doximity Inc Stock (DOCS) Company Profile
Firmenname
Doximity Inc
Sektor
Branche
Telefon
(650) 549-4330
Adresse
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Compare DOCS vs VEEV, BTSG, TEM, HNGE, HQY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
30.97 | 5.52B | 644.86M | 196.05M | 317.50M | 0.9812 |
VEEV
Veeva Systems Inc
|
310.36 | 50.25B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
60.87 | 12.04B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
64.72 | 11.75B | 1.36B | -302.91M | -219.93M | -1.7182 |
HNGE
Hinge Health Inc
|
99.16 | 8.00B | 646.34M | -512.40M | 202.76M | -6.6871 |
HQY
Healthequity Inc
|
92.03 | 7.61B | 1.34B | 230.70M | 440.96M | 2.6695 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-08-10 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2026-06-29 | Herabstufung | BofA Securities | Buy → Underperform |
| 2026-05-15 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2026-05-14 | Herabstufung | BTIG Research | Buy → Neutral |
| 2026-05-14 | Herabstufung | Jefferies | Buy → Hold |
| 2026-05-14 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2026-05-14 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2026-05-14 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2026-04-20 | Herabstufung | Truist | Buy → Hold |
| 2026-04-08 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2026-02-09 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2026-02-06 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2026-01-20 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2026-01-09 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2026-01-08 | Hochstufung | Truist | Hold → Buy |
| 2025-12-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-11-21 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-10-27 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-10-10 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2025-10-01 | Herabstufung | Goldman | Neutral → Sell |
| 2025-07-09 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-06-02 | Hochstufung | BTIG Research | Neutral → Buy |
| 2025-02-07 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-02-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-12-20 | Eingeleitet | Stephens | Equal-Weight |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-11-15 | Eingeleitet | Goldman | Neutral |
| 2024-11-14 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-13 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2024-11-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-11-08 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-10-15 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-08-09 | Hochstufung | Needham | Hold → Buy |
| 2024-07-18 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-04-25 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2024-01-02 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-08-09 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-08-09 | Herabstufung | Needham | Buy → Hold |
| 2023-08-03 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-05-01 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-01-06 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-10-31 | Eingeleitet | Wells Fargo | Overweight |
| 2022-10-24 | Eingeleitet | Evercore ISI | In-line |
| 2022-10-13 | Eingeleitet | BTIG Research | Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-08-05 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-07-28 | Eingeleitet | Berenberg | Buy |
| 2022-05-18 | Bestätigt | BofA Securities | Neutral |
| 2022-05-18 | Bestätigt | Goldman | Buy |
| 2022-05-18 | Bestätigt | Guggenheim | Buy |
| 2022-05-18 | Bestätigt | Jefferies | Buy |
| 2022-05-18 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-05-18 | Bestätigt | Needham | Buy |
| 2022-04-07 | Eingeleitet | Guggenheim | Buy |
| 2022-04-04 | Eingeleitet | BofA Securities | Neutral |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2021-12-14 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-11-17 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-11-10 | Bestätigt | Canaccord Genuity | Buy |
| 2021-11-10 | Bestätigt | Goldman | Neutral |
| 2021-11-10 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2021-11-10 | Bestätigt | Needham | Buy |
| 2021-11-10 | Bestätigt | Piper Sandler | Overweight |
| 2021-08-26 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-07-19 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-07-19 | Eingeleitet | Goldman | Neutral |
| 2021-07-19 | Eingeleitet | JP Morgan | Overweight |
| 2021-07-19 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-07-19 | Eingeleitet | Piper Sandler | Overweight |
| 2021-07-19 | Eingeleitet | Raymond James | Outperform |
| 2021-07-19 | Eingeleitet | SVB Leerink | Outperform |
| 2021-07-19 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Doximity Inc Aktie (DOCS) Neueste Nachrichten
ROSEN, LEADING INVESTOR COUNSEL, Encourages Millrose Properties, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionMRP - GlobeNewswire Inc.
DOCS INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Doximity, Inc. Investors with Substantial Losses May Seek to Lead Class Action Lawsuit Before November 16, 2026 Deadline - PR Newswire
DOCS UPCOMING DEADLINE: Levi & Korsinsky Alerts Doximity, Inc. Stockholders of Securities Class ActionContact the Firm - FinancialContent
DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit with SBS Law - GlobeNewswire
Fort Washington Investment Advisors Inc. OH Sells 368,718 Shares of Doximity, Inc. $DOCS - MarketBeat
Kaplan Fox Announces a Securities Class Action Filed Against Doximity, Inc. (NYSE: DOCS)Lead Plaintiff Deadline is November 16, 2026 - Barchart.com
Doximity Settles Remaining OpenEvidence AI Prompt-Hack Dispute - Bloomberg Law News
Doximity, Inc. (DOCS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
Bronstein, Gewirtz & Grossman LLC Urges Doximity, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.
Doximity Deepens U.S. News Alliance to Improve Patient Access to Care - Zacks Investment Research
Doximity Deepens U.S. News Alliance to Improve Patient Access to Care - Yahoo Finance
DOCS Shareholder Alert: Doximity, Inc. Securities Class Action LawsuitInvestors Should Contact SueWallSt - PR Newswire
Doximity, Inc. (DOCS) Stock Forecasts - Yahoo Finance
DOCS Stockholders Have RightsIf you Lost Money Investing in Doximity, Inc. Contact Robbins LLP for Information About Recovering Your Losses - PR Newswire
Officer Siddharth Sitaram proposes selling 2,613 Doximity (DOCS) shares. - Stock Titan
DOCS DEADLINE: Levi & Korsinsky Reminds Doximity, Inc. Investors of Upcoming Securities Class Action Deadline - Morningstar
Doximity, Inc. (DOCS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
ROSEN, REGARDED INVESTOR COUNSEL, Encourages Doximity, Inc. - GlobeNewswire
DOXIMITY, INC. (DOCS) SHAREHOLDER ALERT Bernstein Liebhard - GlobeNewswire
Doximity Extends Partnership With US News & World Report - Yahoo Finance
Doximity and U.S. News & World Report Extend Partnership to Connect Patients with Hospitals and Doctors - Business Wire
Deadline Alert: Doximity, Inc. (DOCS) Shareholders Who Lost - GlobeNewswire
Bronstein, Gewirtz & Grossman LLC Urges Doximity, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire
Tempus AI Expands Strategic Collaborations to Drive Future Growth - Zacks Investment Research
רוזן, משפטן מדורג מוביל גלובלי, מעודד את משקיעי Doximity, Inc לגייס ייעוץ משפטי לפני המועד האחרון החשוב בתביעה ייצוגית בניירות ערך – DOCS - GlobeNewswire Inc.
Sprout Social Investor News: If You Own Stock in Sprout Social, Inc., You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DOCS - GlobeNewswire Inc.
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 16, 2026 in Doximity, Inc. LawsuitDOCS - FinancialContent
Kaplan Fox Continues to Alert Investors of a Securities Class Action Deadline on November 16, 2026 Against Doximity, Inc. (NYSE: DOCS) - Barchart.com
Is Doximity (DOCS) Below Fair Value Following The AI Spending Surge? - Yahoo Finance
Reflecting On Vertical Software Stocks’ Q2 Earnings: Doximity (NYSE:DOCS) - TradingView
A Look at Doximity Inc (DOCS) After 6.1% Gain -- GF Value $45.93 vs Price $29.38 - GuruFocus
Palantir Technologies, Doximity, Snowflake, and Teradata Shares Skyrocket, What You Need To Know - Yahoo Finance
DOCS ALERT: Bragar Eagel & Squire, P.C. Reminds Doximity, - GlobeNewswire
SueWallSt Reminds Doximity, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 16, 2026DOCS - Morningstar
SueWallSt Reminds Doximity, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 16, 2026DOCS - PR Newswire
SueWallSt Reminds Doximity, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 16, 2026DOCS - TradingView
Doximity, Inc. (DOCS) Stock Forecasts - Yahoo Finance
Deadline Alert: Doximity, Inc. (DOCS) Shareholders Who Lost - GlobeNewswire
DEADLINE ALERT for BETR, DOCS, BIDU, UWMC: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions - GlobeNewswire Inc.
DOCS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
DOCS Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Doximity, Inc. Securities LawsuitContact Levi & Korsinsky - PR Newswire
DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit with SBS Law - GlobeNewswire
Insider Selling: Doximity (NYSE:DOCS) Director Sells 2,000 Shares of Company Stock - MarketBeat
Doximity (DOCS) Surpasses Market Returns: Some Facts Worth Knowing - Yahoo Finance UK
Doximity (DOCS) Surpasses Market Returns: Some Facts Worth Knowing - Zacks Investment Research
Doximity (DOCS) Surpasses Market Returns: Some Facts Worth Knowing - Yahoo Finance
Kaplan Fox Encourages Doximity, Inc. (NYSE: DOCS) Investors Seeki - The National Law Review
Deadline Alert: Doximity, Inc. (DOCS) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit - GlobeNewswire Inc.
Deadline Alert: Doximity, Inc. (DOCS) Shareholders Who Lost - GlobeNewswire
Finanzdaten der Doximity Inc-Aktie (DOCS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Doximity Inc-Aktie (DOCS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Wampler Kira Scherer | Director |
Oct 01 '26 |
Sale |
28.91 |
2,000 |
57,820 |
27,923 |
| KIRA WAMPLER | Director |
Oct 01 '26 |
Proposed Sale |
28.91 |
2,000 |
57,820 |
0 |
| PHOEBE L YANG WATKIN | Director |
Sep 30 '26 |
Proposed Sale |
26.71 |
1,290 |
34,456 |
0 |
| Yang Watkin Phoebe L. | Director |
Sep 30 '26 |
Sale |
26.71 |
1,290 |
34,456 |
24,744 |
| Sitaram Siddharth | Chief Accounting Officer |
Sep 15 '26 |
Sale |
26.02 |
2,077 |
54,044 |
96,045 |
| SIDDHARTH SITARAM | Officer |
Sep 15 '26 |
Proposed Sale |
26.02 |
2,077 |
54,044 |
0 |
| Wampler Kira Scherer | Director |
Sep 01 '26 |
Sale |
26.33 |
2,000 |
52,660 |
27,923 |
| KIRA WAMPLER | Director |
Sep 01 '26 |
Proposed Sale |
26.33 |
2,000 |
52,660 |
0 |
| KIRA WAMPLER | Director |
Aug 25 '26 |
Proposed Sale |
24.95 |
2,000 |
49,900 |
0 |
| Wampler Kira Scherer | Director |
Aug 25 '26 |
Sale |
24.95 |
2,000 |
49,900 |
19,839 |
3.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):